2Suppliers
7Customers
3Debt Items
7Related Chains

Neuronetics, Inc. Suppliers

TickerNameConfidenceEvidence
MADRYN-ASSET-MANAGEMENT-LP MADRYN-ASSET-MANAGEMENT-LP 80% In connection with and prior to closing of the Arrangement, Madryn Asset Management, LP and its affiliates (collectively, "Madryn") converted (i) all of the outstanding amount owing under Greenbrook'…
SPRAVATO-DRUG-MANUFACTURERS SPRAVATO-DRUG-MANUFACTURERS 60% If the Company's inventory of SPRAVATO is damaged or expires, we may not be able to sell products for which it has paid, which may delay our accounts receivable collection, impair our cash flow and l…

Neuronetics, Inc. Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-DEFENSE USGOV-DEPARTMENT-OF-DEFENSE 95% USAspending awards from Department of Defense: $811,010 across 3 awards. W91YTZ21C0007 NEW TMS TRANSCRANIAL MAGNETIC STIMULATION; N0025922P0124 THERAPEUTIC MAGNETIC SYSTEM ANNUAL MAINT MODEL # 81-003…
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS 95% USAspending awards from Department of Veterans Affairs: $29,400 across 2 awards. 36C25623P0398 NEURONETICS NEUROSTAR TMS THERAPY SYSTEM; 36C25023P0054 HIGHLY SPECIALIZED HOSPITAL EQUIPMENT SERVICE AG…
GREENBROOK GREENBROOK 90% For the year ended December 31, 2025, our U.S. revenues were $146.0 million, compared to $72.5 million for the year ended December 31, 2024, which represented an increase of 101% compared to the prio…
MOLEX-INCORPORATED MOLEX-INCORPORATED 85% upply through our operations team based in Malvern, Pennsylvania. We outsource the manufacturing of components and high-level assemblies, which are produced and tested to our specifications. We rely …
JAPANESE-EXCLUSIVE-DISTRIBUTOR JAPANESE-EXCLUSIVE-DISTRIBUTOR 80% We currently market and sell our products outside of the United States, including through our exclusive distribution agreement in Japan.
GREENBROOK-S-LARGEST-SUPPORTED-PHYSICIAN-GROUPS GREENBROOK-S-LARGEST-SUPPORTED-PHYSICIAN-GROUPS 70% The owner of Greenbrook's largest supported physician groups has notified Greenbrook that he intends to transition out of the relationship by October 1, 2026.
THIRD-PARTY-PAYORS THIRD-PARTY-PAYORS 70% If contracted healthcare provider practices are unable to obtain payment from the applicable third-party payors or, if applicable, patients, they may not be paid for services rendered, which may dela…

Neuronetics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
STIM-DEBT-12785 Warrants outstanding: 2521000 90% xbrl warrant detail from xbrl 2024-12-31.
STIM-DEBT Debt stack $85.4M 90% Market cache reports total debt of $85.4M.
STIM-DEBT-12786 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-12-31.

Neuronetics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Neuronetics, Inc..

Neuronetics, Inc. Ownership

HolderNameConfidenceEvidence
STIM-OWNER-MADRYN-ASSET-MANAGEMENT-LP Madryn Asset Management, LP 90% 13F overlay lists Madryn Asset Management, LP as top holder; 103 tracked holders.

Neuronetics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ARQT Arcutis Biotherapeutics, Inc. 100.00 2
ARDX Ardelyx, Inc. 100.00 2
GSL Global Ship Lease, Inc. 50.00 2
RZLT Rezolute, Inc. 50.00 2
SLRC SLR Investment Corp. 38.88 1 ['receiving']
TMCI Treace Medical Concepts, Inc. 14.78 2
OM Outset Medical, Inc. 14.78 2